throbber
Elastase activated liposomal delivery to nucleated cells
`
`Charles C. Pak, Ravi K. Erukulla, Patrick L. Ahl, Andrew S. Jano¡, Paul Meers *
`
`The Liposome Company, 1 Research Way, Princeton, NJ 08540, USA
`
`Received 5 August 1998; received in revised form 9 December 1998; accepted 9 December 1998
`
`Abstract
`
`The specific activation of liposomes for delivery has been explored by enzyme mediated cleavage of a peptide substrate
`covalently conjugated to a fusogenic lipid. We have previously shown an elastase sensitive peptide conjugated to 1,2-dioleoyl-
`sn-glycero-3-phosphatidylethanolamine (DOPE) could be activated by enzymatic cleavage, triggering liposome-liposome
`lipid mixing and fusion with erythrocyte ghosts (Pak et al., Biochim. Biophys. Acta, 1372 (1998) 13^27). Further
`optimization of this system has been aimed at obtaining substrate cleavage at or below physiological elastase levels and to
`demonstrate triggered delivery to living cells. Therefore a new peptide-lipid, MeO-suc-AAPV-DOPE (N-methoxy-succinyl-
`Ala-Ala-Pro-Val-DOPE), has been developed that exhibits greater sensitivity and selectivity for elastase cleavage and
`subsequent conversion to DOPE. This peptide-lipid was used with DODAP (dioleoyl dimethylammonium propane, a pH
`dependent cationic lipid) in a 1:1 mol ratio with the expectation that endocytosis would lead to a liposome with an overall
`positive charge if enzymatic cleavage had occurred. Elastase treated liposomes displayed pH dependent enhancement of
`binding, lipid mixing, and delivery of 10 000 MW dextrans, relative to untreated liposomes, when incubated with HL60
`human leukemic cells. Heat denatured elastase did not activate DODAP/MeO-suc-AAPV-DOPE liposomes, indicating
`enzymatic activity of elastase is necessary. Liposomes bound to ECV304 endothelial cells at physiological pH could be
`activated by elastase to deliver an encapsulated fluorescent probe, calcein, into the cell cytoplasm. These results suggest
`enzyme substrate peptides linked to a fusogenic lipid may be used to elicit specific delivery from liposomes to cells. (cid:223) 1999
`Elsevier Science B.V. All rights reserved.
`
`Keywords: Liposome; Fusion; Elastase; Peptide; Lipid; Cleavage
`
`1. Introduction
`
`A paradox of liposomal delivery vehicles is the
`
`requirement for liposomal membranes that are both
`stable and yet capable of undergoing fusion or desta-
`bilization at the desired site, so as to elicit delivery of
`
`0005-2736 / 99 / $ ^ see front matter (cid:223) 1999 Elsevier Science B.V. All rights reserved.
`PII: S 0 0 0 5 - 2 7 3 6 ( 9 8 ) 0 0 2 5 6 - 9
`
`

`

`112
`
`C.C. Pak et al. / Biochimica et Biophysica Acta 1419 (1999) 111^126
`
`the contents of the liposome into the cell. We have
`previously described the use of enzymatic cleavage to
`trigger liposomal fusion and contents delivery [1].
`Although other triggers have been utilized to induce
`liposomal fusion or membrane destabilization [2^7],
`activation by enzyme cleavage has several advantages
`over these methods.
`Elevated enzyme activity is associated with numer-
`ous pathological conditions. Metastatic cancer cells
`display enhanced extracellular activity of several deg-
`radative enzymes, such as matrix metalloproteinases
`and urokinase-type plasminogen activator (for re-
`view see [8]). Elevated enzymatic activity facilitates
`the extravasation of these cells from the circulation
`and increases their invasive potential. In£ammatory
`conditions such as cystic ¢brosis [9^12], rheumatoid
`arthritis [13,14], and emphysema [15,16] are accom-
`panied by an increase in extracellular elastase activity
`due to release of elastase from phagocytic cells. Ele-
`vated elastase activity appears to be due, in part, to
`an imbalance in the elastase/anti-protease ratio
`[9,17,18]. Elastase has also been associated with tu-
`mor progression and development [19^21]. The ubiq-
`uitous yet speci¢c nature of disease-associated enzy-
`matic activity,
`its
`localization near or on the
`membranes of cells involved in tissue remodeling
`[22,23] and its association with several pathologies
`provide numerous opportunities for triggering specif-
`ic liposomal delivery to desired targets using the ac-
`tivity of such enzymes. The triggering event would be
`expected to convert the liposome from a relatively
`inert state to a fusogenic state and may even trigger
`speci¢c binding depending on the design.
`The selectivity of
`liposomal activation can be
`modulated by the choice of an enzyme substrate con-
`jugated to a fusogenic lipid so that enzymatic cleav-
`age releases or unmasks fusogenic lipids. Thus lip-
`osomes may be designed for a selected site of
`activation and hence liposomal delivery could be tar-
`geted. We have chosen to use elastase mediated trig-
`gering of liposomal fusion as a model for the general
`principle of enzymatically activated delivery via lip-
`osomes.
`We have previously described the activation of lip-
`osomal lipid mixing and fusion by enzyme triggering
`[1]. A peptide-lipid consisting of N-Ac-Ala-Ala-, an
`elastase sensitive peptide sequence, was conjugated to
`the headgroup of DOPE (1,2-dioleoyl-sn-glycero-3-
`
`phosphatidylethanolamine), a known fusogenic lipid.
`The fusogenic potential of this peptide-lipid, N-Ac-
`AA-DOPE, was limited until enzymatic cleavage of
`the peptide regenerated DOPE. Liposomes contain-
`ing N-Ac-AA-DOPE could be triggered to lipid mix
`with target liposomes and fuse with RBC ghosts.
`Although N-Ac-AA-DOPE was capable of demon-
`strating the utility of enzyme-triggered fusion, phys-
`iological relevance requires greater sensitivity to en-
`zyme activation, demonstration of delivery to
`nucleated living cells and ultimately the ability to
`deliver in the physiological milieu which may include
`serum proteins. We chose to address the ¢rst two of
`these problems in this report.
`First, it is necessary to demonstrate that the choice
`of an appropriate peptide can be used to optimize
`the cleavage and triggering for the desired target at
`physiological levels of the enzyme. Powers et al. [24]
`had shown that the peptide sequence MeO-suc-Ala-
`Ala-Pro-Val- was highly sensitive to elastase cleav-
`age. Therefore we hypothesized that this sequence
`when conjugated to DOPE would create a trigger-
`able peptide-lipid with greater sensitivity. In this
`study a new peptide-lipid, MeO-suc-AAPV-DOPE,
`was tested for elastase mediated DOPE generation.
`Included in this e¡ort was the introduction of a lipid
`that would reduce the surface charge of the liposome
`compared to the previous version to enhance inter-
`action of the positively charged enzyme, elastase,
`with the substrate. A second goal was to demonstrate
`delivery to nucleated cells, where at least some deliv-
`ery may occur via an endosomal compartment. Lip-
`osomes were designed to take advantage of the low
`pH in that compartment in a manner that would also
`enhance elastase triggering. Here we report a liposo-
`mal system that could be shown for the ¢rst time, to
`be triggered by physiological
`levels of elastase to
`undergo lipid mixing with and aqueous contents de-
`livery to nucleated cells.
`
`2. Materials and methods
`
`2.1. Reagents
`
`Human leukocyte elastase was purchased from
`Calbiochem (San Diego, CA, USA). Lipids were pur-
`chased from Avanti Polar Lipids (Alabaster, AL,
`
`BBAMEM 77557 8-7-99 Cyaan Magenta Geel Zwart
`
`

`

`C.C. Pak et al. / Biochimica et Biophysica Acta 1419 (1999) 111^126
`
`113
`
`USA) and were of 99% or greater purity. Calcein
`( s 95% pure),
`tetramethyl
`rhodamine dextran
`(TMR-dextran), and streptavidin were from Molec-
`ular Probes (Eugene, OR, USA). Biotinylated-wheat
`germ agglutinin (WGA) was obtained from Pierce
`(Rockford,
`IL, USA). MeO-suc-Ala-Ala-Pro-Val-
`OH used for covalent
`linkage with DOPE was
`from Bachem Bioscience (King of Prussia, PA,
`USA). RPMI 1640, fetal bovine serum (FBS), and
`HBSS (Hanks’ balanced salt solution) were pur-
`chased from Life Technologies (Gaithersburg, MD,
`USA). Medium 199 was purchased from BioWhit-
`taker (Walkersville, MD, USA). 1,3-Dicyclohexyl-
`carbodiimide
`(DCC),
`4-dimethylaminopyridine
`(DMAP), p-nitrophenol and triethylamine were ob-
`tained from Sigma (St. Louis, MO, USA). TMD-8
`ion exchange resin was purchased from Aldrich (Mil-
`waukee, WI, USA). HPLC-grade solvents, tetrahy-
`drofuran (THF), chloroform and methanol were pur-
`chased from Baxter (McGaw Park, IL, USA). All
`chemicals and solvents were used without further
`puri¢cation.
`
`2.2. Cells
`
`HL60 human leukemia and ECV304 human endo-
`thelial cells were obtained from ATCC (Rockville,
`MD, USA). HL60 cells were passaged as suspension
`cultures in RPMI 1640 supplemented with 10% heat
`inactivated FBS. Adherent ECV304 cells were grown
`in medium 199 supplemented with 10% heat inacti-
`vated FBS. Greater than 98% viability was observed
`during routine tissue culture.
`
`2.3. Synthesis and characterization of N-methoxy-
`succinyl alanine alanine proline valine 1,2-
`dioleoyl-sn-glycero-3-phosphatidylethanolamine
`(MeO-suc-AAPV-DOPE)
`
`2.3.1. MeO-suc-AAPV-p-nitrophenyl ester
`To a solution of MeO-suc-AAPV-H peptide (540
`mg, 1.15 mmol) was added 142 mg (1.38 mmol) of p-
`nitrophenol, 175 mg (1.38 mmol) of DCC and a cat-
`alytic amount (a few crystals) of DMAP in 10 ml of
`dry chloroform. The reaction mixture was stirred
`overnight under nitrogen atmosphere at room tem-
`perature. At this point TLC (thin layer chromatog-
`raphy) analysis showed that the reaction had gone to
`
`completion. The precipitate, dicyclohexylurea, from
`the reaction mixture was ¢ltered using a G-2 funnel
`and the ¢ltrate concentrated under reduced pressure.
`The residual material was used in next step without
`puri¢cation.
`
`2.3.2. MeO-suc-AAPV-1,2-dioleoyl-sn-glycero-
`3-phosphatidylethanolamine
`To a solution of p-nitrophenyl ester of MeO-suc-
`AAPV-OH (600 mg, 1.01 mmol) was added 604 mg
`(0.81 mmol) of 1,2-dioleoyl-sn-glycero-3-phospho-
`ethanolamine and 82 mg (113 ml, 0.81 mmol) of tri-
`ethylamine in 20 ml of chloroform:tetrahydrofuran
`(1:4 v/v). The reaction mixture was stirred under
`nitrogen atmosphere at room temperature overnight.
`TLC analysis showed that the reaction had gone to
`the completion. The reaction mixture was concen-
`trated under reduced pressure and passed through
`activated TMD-8 ion exchange resin in THF:H2O
`(9:1 v/v). The phosphorus positive fractions were
`pooled and concentrated to get a residual product.
`The residual material was puri¢ed with silica gel col-
`umn chromatography (the column was washed with
`5% methanol in chloroform, then eluted with chloro-
`form:methanol:ammonium
`hydroxide
`65:25:4
`v/v/v), giving 915 mg (95% yield on the basis of
`DOPE), which on lyophilization gave a white solid.
`The lipopeptide molecule tested positive with a mo-
`lybdenum reagent and negative with a ninhydrin
`reagent. By TLC the lipopeptide gave a single spot
`and s 99% purity. The lipopeptide was also charac-
`terized by NMR and FAB mass spec analysis. Some
`characteristic 1H-NMR signals (300 MHz, CDCl3)
`are shown here: d 0.87 (t, 3H, J = 7.15 Hz), 1.27
`(40H), 1.56 (4H), 2.0 (8H), 2.23 (t, 4H, J = 7.15
`Hz), 5.17 (1H), 5.32 (4H, J = 3.12 Hz). The 31P-
`NMR spectrum (121.5 MHz, CDCl3) gave a single
`signal. FAB (M(cid:135)) calculated for C62H109N5O15P was
`1195.55, and masses of 1196.8 (MH(cid:135)) and 1234.9
`(MK(cid:135)) were observed.
`
`2.4. Liposome preparation
`
`Large vesicles were prepared by aliquoting desired
`amounts of
`lipid from chloroform stocks
`into
`13U100 mm pyrex tubes and drying under a nitro-
`gen stream. After exposure to high vacuum 4 h
`overnight the lipid ¢lm was hydrated in 10 mM
`
`BBAMEM 77557 8-7-99 Cyaan Magenta Geel Zwart
`
`

`

`114
`
`C.C. Pak et al. / Biochimica et Biophysica Acta 1419 (1999) 111^126
`
`(N-tris[hydroxymethyl]methyl-2-aminoethane-
`TES
`sulfonic acid), 154 mM NaCl, 0.1 mM EDTA (ethyl-
`enediamine tetraacetic acid), pH 7.4. Unless speci¢ed
`otherwise, this bu¡er was used for all experiments.
`After vortexing, samples were freeze-thawed 8U and
`extruded under pressure 10U (Lipex, Vancouver,
`BC, Canada) through 0.1 Wm polycarbonate ¢lters
`(Nucleopore, Pleasanton, CA, USA). Liposomes
`were stored at 4‡C until used.
`Fluorescent dextran containing liposomes were
`prepared by hydrating
`the DODAP/MeO-suc-
`AAPV-DOPE lipid ¢lm with a 50 mg/ml solution
`of 10 000 MW TMR-dextran in TES/NaCl/EDTA
`bu¡er. Liposomes were then vortexed, freeze-thawed,
`and extruded through 0.1 Wm ¢lters as described
`above. To remove unencapsulated dextran the lipo-
`some solution was extensively dialyzed with the TES/
`NaCl/EDTA bu¡er using a Biodialyser (Sialomed,
`Columbia, MD, USA) ¢tted with 50 nm pore size
`¢lters. Calcein loaded liposomes were prepared by
`hydrating the lipid ¢lm in the presence of bu¡er con-
`taining 50 mM calcein. The calcein solution was pH
`and osmolarity adjusted prior to preparation of lip-
`osomes. Calcein loaded liposomes contained 0.75
`mol% N-Rho-PE to monitor liposome binding. After
`preparation of large vesicles as described above, cal-
`cein loaded liposomes were transferred to a 10 000
`MWCO Slide-A-Lyzer (Pierce, Rockford, IL, USA)
`and extensively dialyzed with TES/NaCl/EDTA bu¡-
`er. The encapsulated volume of these liposomes was
`0.8 l/mol of lipid. Sonicated vesicles were prepared
`by drying lipid in the same manner as described
`above but preparations were vortexed then water
`bath sonicated for s 10 min at room temperature.
`Lipid concentration was monitored by phosphate as-
`say [25]. The size of liposomes was veri¢ed by quasi-
`elastic light scattering using a Nicomp submicron
`particle sizer (Particle Sizing Systems, Santa Barbara,
`CA, USA). Freeze-thaw-extrusion vesicles and soni-
`cated vesicles were 70^80 nm and 35^45 nm in diam-
`eter, respectively, as determined by number weighted
`Gaussian analysis.
`
`2.5. Detection of MeO-suc-AAPV-DOPE cleavage
`
`2.5.1. TLC detection of MeO-suc-AAPV-DOPE
`cleavage
`100 nmol of MeO-suc-AAPV-DOPE sonicated
`
`vesicles were incubated with 0, 5, or 10 Wg elastase
`in 0.4 ml TES/NaCl/EDTA bu¡er, pH 7.4, overnight
`at 37‡C. Lipid was extracted by organic phase sepa-
`ration [26], dried under N2 stream, and exposed to
`vacuum for 4 h. Samples were resuspended in chloro-
`form and spotted onto TLC plates. TLC was run
`using chloroform:methanol:ammonium hydroxide
`(65:25:5), air dried,
`sprayed with molybdenate
`blue, and charred on a hot plate.
`
`2.5.2. 31P-NMR analysis
`DODAP/MeO-suc-AAPV-DOPE (1:1 mol ratio)
`freeze-thaw-extrusion vesicles were prepared and
`treated with or without elastase (0^50 Wg protein/
`1000 nmol lipid/4 ml) for 2 h in TES/NaCl/EDTA
`bu¡er, pH 7.4, at 37‡C. Liposomes were transferred
`to 13U64 mm polyallomer centrifuge tubes (Beck-
`man, Palo Alto, CA, USA), and pelleted by ultra-
`centrifugation at 149 000Ug for 1 h at 4‡C with a
`L5-50E ultracentrifuge (Beckman, Palo Alto, CA,
`USA). The liposome pellet (approximately 90% of
`the total) was resuspended in 100 Wl TES/NaCl/
`EDTA bu¡er, to which 400 Wl of 10% deoxycholate,
`100 mM EDTA, 20 mM HEPES, pH 7.4, bu¡er and
`200 Wl of deuterium oxide (Cambridge Isotope Lab-
`oratories, Woburn, MA, USA) were added. After
`transfer to 5 mm NMR tubes samples were moni-
`tored at room temperature in a Bruker AC300 spec-
`trometer operating at 121.5 MHz, with 110 Ws 90‡
`radio frequency pulse for proton decoupling and set
`to 2 s interpulse delay to avoid signal saturation.
`Sweep width was set at 50 kHz. 1 Hz line broadening
`was applied to all spectra. Peaks were identi¢ed by
`comparison with standards run under identical con-
`ditions.
`
`2.6. Binding and lipid mixing of liposomes to HL60
`cells
`
`Lipid mixing was monitored by the N-NBD-PE/N-
`Rho-PE resonance energy transfer assay, as de-
`scribed [27]. Liposomes were prepared with 0.75
`mol% N-NBD-PE and 0.75 mol% N-Rho-PE, which
`results in quenching of the N-NBD-PE £uorescence
`signal. Membrane fusion results in probe di¡usion
`and relief from self-quenching, which is monitored
`as an increase in N-NBD-PE £uorescence. DO-
`DAP/MeO-suc-AAPV-DOPE (1:1 mol:mol)
`lipo-
`
`BBAMEM 77557 8-7-99 Cyaan Magenta Geel Zwart
`
`

`

`C.C. Pak et al. / Biochimica et Biophysica Acta 1419 (1999) 111^126
`
`115
`
`somes were incubated in TES/NaCl/EDTA bu¡er (cid:254)
`elastase (5 Wg/100 nmol lipid, 250 WM lipid concen-
`tration) for 2 h at 37‡C, pH 7.4. HL60 cells were
`washed with TES/NaCl/EDTA bu¡er and incubated
`with liposomes (1U106 cells, 10 nmol liposome) in
`200 Wl TES/NaCl/EDTA bu¡er. Samples were either
`at pH 7.4 or adjusted to pH 5 by the addition of
`dilute HCl. All samples were shaken in an Eppendorf
`Thermomixer (Brinkmann Instruments, Inc., West-
`bury, NY, USA), 700 rpm, for 30 min at 37‡C. There
`was no reduction in cell viability following this pro-
`cedure, as detected by trypan blue exclusion (unpub-
`lished data). Cells were then washed with TES/NaCl/
`EDTA bu¡er, pH 7.4, and transferred to Falcon 24
`well plates (Becton Dickinson, Lincoln Park, NJ,
`USA). Fluorescence was monitored in a Cyto£uor
`II multiwell £uorescence plate reader (Perseptive Bio-
`systems, Framingham, MA, USA) with a quartz
`halogen lamp using 450 nm excitation/530 nm emis-
`sion or 560 nm excitation/620 nm emission wave-
`lengths for N-NBD-PE or N-Rho-PE £uorescence,
`respectively. Liposome binding was determined as
`the amount of N-Rho-PE £uorescence associated
`with washed cells relative to total £uorescence of lip-
`osomes added. This percentage was converted to
`number of liposomes bound by multiplying by the
`number of liposomes added (assuming all liposomes
`were 100 nm in diameter and 105 lipid molecules/0.1
`Wm diameter liposome. Therefore 6.02U1010 lipo-
`somes of 0.1 Wm diameter were added per sample).
`The % £uorescence dequenching (FDQ) was calcu-
`lated by the following formula:
`(cid:137)(cid:133)F t=F max cells(cid:134)3(cid:133)F o alone=F max alone (cid:134)(cid:138)=
`(cid:137)13(cid:133)F o alone=F max alone(cid:134)(cid:138)U100
`where Ft = N-NBD-PE £uorescence of liposomes in-
`cubated with cells at a given time, Fo alone = initial
`N-NBD-PE £uorescence of liposomes only, Fmax cells
`and Fmax alone = maximal N-NBD-PE £uorescence of
`liposomes incubated either with cells or alone, re-
`spectively, as determined by addition of 0.5%
`C12E8 detergent. FDQ was assumed to result from
`all-or-none lipid mixing of
`liposomes with cells.
`Therefore % FDQ could be converted to number
`of liposomes mixed by simple multiplication of the
`total. This was done to take into account both the
`
`enhancement of binding and the lipid mixing after
`elastase activation.
`
`2.7. DODAP/MeO-suc-AAPV-DOPE
`liposome-ECV304 binding, lipid mixing, and
`calcein delivery
`
`Liposomes were bound to adherent ECV304 cells
`via a biotin-streptavidin linkage. To this end DO-
`DAP/MeO-suc-AAPV-DOPE (1:1 mol:mol)
`lipo-
`somes were prepared with 0.3 mol% N-biotinyl cap-
`roylamine-PE as well as £uorescent lipid probes or
`with encapsulated calcein. ECV304 cells were washed
`with HBSS bu¡er and then incubated sequentially at
`room temperature with biotin-WGA (20 Wg/ml) and
`streptavidin (40 Wg/ml) prepared in HBSS, 30 min/
`treatment. Cells were washed after each treatment.
`Liposomes were treated with or without elastase as
`described above. Certain aliquots of pretreated DO-
`DAP/MeO-suc-AAPV-DOPE (1:1 mol/mol)
`lipo-
`somes were freeze-thawed after dialysis and prior to
`the addition to cells to release the liposomal con-
`tents. Such freeze-thawed liposomes were exposed
`to a liquid nitrogen-37‡C water bath for 5 cycles.
`The self-quenching of calcein was reduced by ap-
`proximately 85% (maximal FDQ determined by de-
`tergent solubilization) after freeze-thawing, indicat-
`ing the release of encapsulated calcein. In all cases,
`50^100 nmol of liposomes were added to con£uent
`ECV304 cell monolayers (1U105 cells/well of a 24
`well plate) and incubated in HBSS for 30 min at
`room temperature to promote N-biotinyl cap-PE
`binding to streptavidin. Unbound liposomes were re-
`moved by repeated washes. After the ¢nal wash,
`fresh HBSS bu¡er was added to all wells and cells
`were incubated at 37‡C for given times. Fluorescence
`was quantitated as described above.
`
`2.8. Fluorescence microscopy of liposome-cell lipid
`mixing and aqueous contents delivery
`
`DODAP/MeO-suc-AAPV-DOPE (1:1 mol/mol)
`liposomes were incubated for 2 h at 37‡C without
`or with elastase (5 Wg protein/100 nmol lipid). Lipo-
`somes containing the £uorescent lipid probes N-
`NBD-PE and N-Rho-PE were bound to HL60 in
`solution as described above. TMR-dextran loaded
`
`BBAMEM 77557 8-7-99 Cyaan Magenta Geel Zwart
`
`

`

`116
`
`C.C. Pak et al. / Biochimica et Biophysica Acta 1419 (1999) 111^126
`
`(40
`liposomes
`DODAP/MeO-suc-AAPV-DOPE
`nmol) were incubated with 1U105 HL60 cells in
`200 Wl TES/NaCl/EDTA bu¡er under pH 5, 37‡C,
`conditions for 30 min to induce binding. Calcein
`loaded DODAP/MeO-suc-AAPV-DOPE liposomes
`were bound to ECV304 cells that had been plated
`on glass coverslips by the biotinylated-WGA-strepta-
`vidin linkage described above. In some experiments
`liposomes were freeze-thawed, as described above,
`prior to the addition to cells. Cells were washed
`with HBSS to remove unbound liposomes and ob-
`served with a Bio-Rad (Hercules, CA, USA) MRC-
`1000
`laser
`scanning
`confocal
`imaging
`system
`equipped with an Olympus BX50 microscope (Olym-
`pus, Lake Success, NY, USA) using an apochromat
`60U oil (N.A. 1.40) objective. Calcein £uorescence
`was excited with the 488 nm line of a krypton/argon
`laser and observed at 522 nm emission. N-Rho-PE
`and TMR-dextran £uorescence were observed with
`the 568 nm line and observed at 605 nm emission.
`Images were frame averaged and false color was ap-
`plied. All images within a ¢gure were obtained under
`identical conditions of confocal iris width, gain, and
`black level. Identical false color look up tables were
`also applied to images within a ¢gure. Average £uo-
`rescence/cell Wm2 of all cells in an image was deter-
`mined with the histogram feature of Bio-Rad Co-
`MOS confocal imaging software.
`
`3. Results
`
`3.1. Cleavage of MeO-suc-AAPV-DOPE by elastase
`
`Cleavage by elastase to yield DOPE is necessary
`for MeO-suc-AAPV-DOPE to act as a trigger for
`liposomal delivery. This was tested by incubating
`MeO-suc-AAPV-DOPE sonicated vesicles with or
`without elastase overnight at 37‡C, after which lipid
`was isolated and analyzed by TLC. Incubation with
`either 5 or 10 Wg elastase/100 nmol lipid resulted in
`the signi¢cant generation of DOPE (Fig. 1), although
`there also appeared to be a slower running phos-
`phate positive component that may represent an in-
`termediate peptide cleavage product. Only minimal
`cleavage of MeO-suc-AAPV-DOPE by proteinase
`K was observed at the same concentrations (unpub-
`lished data), indicating the tetrapeptide sequence is a
`
`Fig. 1. Elastase mediated cleavage of MeO-suc-AAPV-DOPE as
`detected by TLC. 100 nmol of MeO-suc-AAPV-DOPE soni-
`cated vesicles were incubated with 0, 5, or 10 Wg elastase in 0.4
`ml bu¡er. After overnight incubation at 37‡C lipid was ex-
`tracted and spotted onto TLC plates. Plates were run with a
`chloroform:methanol:ammonium hydroxide (65:25:5)
`solvent
`system and visualized by charring. Lane 1: MeO-suc-AAPV-
`DOPE only; lane 2: +5 Wg elastase;
`lane 3: +10 Wg elastase;
`lane 4: 20 Wg DOPE.
`
`more selective target than the previously studied
`N-Ac-AA-dipeptide [1].
`The
`conversion of MeO-suc-AAPV-DOPE to
`DOPE was also quantitated by 31P-NMR. Since sub-
`sequent experiments employed liposomes containing
`both DODAP and MeO-suc-AAPV-DOPE, vesicles
`with a 1:1 (mol:mol) ratio of these two components
`were prepared by the freeze-thaw-extrusion method
`(see Section 2) and incubated at 37‡C for 2 h with
`increasing amounts of elastase (0^5 Wg elastase/100
`nmol lipid). 31P-NMR analysis demonstrated an elas-
`tase concentration dependent cleavage of MeO-suc-
`AAPV-DOPE and appearance of DOPE (Fig. 2, sol-
`id line). A small shoulder that may represent an in-
`complete peptide cleavage product was also observed
`near the original peptide-lipid peak (unpublished
`data). Treatment with 5 Wg elastase/100 nmol lipid
`yielded 20% DOPE. Longer incubation may have led
`to further digestion, though multiple lamellae and/or
`the surface charge of the liposome may limit the
`
`BBAMEM 77557 8-7-99 Cyaan Magenta Geel Zwart
`
`

`

`C.C. Pak et al. / Biochimica et Biophysica Acta 1419 (1999) 111^126
`
`117
`
`AAPV-DOPE to DOPE is within concentrations
`that are physiologically or therapeutically relevant,
`with the caveat that the e¡ect of serum proteins
`must still be established.
`
`3.2. Optimum DODAP/MeO-suc-AAPV-DOPE
`composition for binding and lipid mixing with
`HL60 cells
`
`MeO-suc-AAPV-DOPE containing liposomes were
`designed to deliver their contents after binding, en-
`docytic internalization, and fusion with and/or dis-
`ruption of the endosomal membrane. DODAP was
`chosen instead of the previously used DOTAP [1]
`because only 20% of the DODAP population is pos-
`itively charged at pH 7.4 [29]. This allows a more
`
`Fig. 3. Optimum DODAP/MeO-suc-AAPV-DOPE liposome
`composition for elastase activation of binding/lipid mixing with
`HL60 cells. DODAP/MeO-suc-AAPV-DOPE liposomes pre-
`pared at 1:3, 1:1, or 3:1 (mol/mol) ratios and labeled with 0.75
`mol% N-NBD-PE and 0.75 mol% N-Rho-PE were incubated
`with or without elastase (5 Wg elastase/100 nmol lipid) for 2 h
`at 37‡C. 10 nmol of liposomes were then mixed with 1U106
`HL60 cells and incubated for 30 min at 37‡C, pH 5. After
`washing twice with 5U volume of TES/NaCl/EDTA bu¡er, pH
`7.4, (A) binding and (B) lipid mixing was determined by moni-
`toring N-Rho-PE and N-NBD-PE £uorescence, respectively.
`
`Fig. 2. Quantitation of elastase mediated cleavage of MeO-suc-
`AAPV-DOPE to DOPE by 31P-NMR. DODAP/MeO-suc-
`AAPV-DOPE (1:1 mol/mol) freeze-thaw-extrusion vesicles were
`incubated with 0, 0.5, 1, 2, 5 Wg elastase/100 nmol lipid. Sam-
`ples were incubated for 2 h at 37‡C, after which liposomes
`were pelleted by ultracentrifugation. Liposomes were solubilized
`and monitored by 31P-NMR. Solid line: % of total MeO-suc-
`AAPV-DOPE converted to DOPE; dotted line: % of expected
`MeO-suc-AAPV-DOPE on outer monolayers
`converted to
`DOPE assuming unilamellar vesicles, i.e. result multiplied by 2.
`
`ultimate amount digested (see Section 4). The max-
`imum exposed peptide-lipid for intact
`liposomes
`would occur with unilamellar vesicles. Assuming
`only the outer lea£et peptide-lipid is available for
`digestion, the minimal percentage conversion of ex-
`posed MeO-suc-AAPV-DOPE to DOPE in the outer
`lea£et lipid was 40% in this situation (Fig. 2, dotted
`line). If the average number of lamellae were greater
`than one, the percentage conversion was even higher.
`In fact, the ratio of encapsulated volume to total
`lipid would appear to indicate an average of approx-
`imately 2.5 lamellae per vesicle for this preparation
`(see Section 2) which would indicate that 100% of
`available peptide-lipid had been cleaved under these
`conditions. The concentration of elastase required to
`produce this amount of cleavage (12.5 Wg elastase/ml)
`is less than the amount of elastase activity found in
`the epithelial lining £uid from patients with cystic
`¢brosis [28]. The contents from human neutrophil
`granules were also able to cleave MeO-suc-AAPV-
`DOPE and generate DOPE (unpublished data).
`The number of neutrophils required to observe this
`e¡ect was less than that observed in epithelial lining
`£uid from cystic ¢brosis patients [28], indicating the
`amount of elastase required to cleave MeO-suc-
`
`BBAMEM 77557 8-7-99 Cyaan Magenta Geel Zwart
`
`

`

`118
`
`C.C. Pak et al. / Biochimica et Biophysica Acta 1419 (1999) 111^126
`
`complete peptide hydrolysis by elastase (unpublished
`data, see Section 4) so that we can model the more
`general case of cleavage on the liposome surface that
`is not a¡ected by the high charge of the enzyme. For
`other enzymatic activators it may be possible to uti-
`lize a permanently positively charged lipid that
`would allow the liposome to become positively
`charged at physiological pH after peptide cleavage,
`so that extracellular binding would be triggered. By
`contrast,
`the tertiary amine of DODAP would
`be fully protonated at pH 5, suggesting liposomes
`containing DODAP would undergo stronger inter-
`action with negatively charged cell membranes within
`the low pH environment of the endocytic compart-
`ment.
`In order to determine the optimum combination of
`DODAP and MeO-suc-AAPV-DOPE for triggerable
`binding and lipid mixing with cells the two lipids
`were formulated into liposomes at di¡erent ratios.
`DODAP/MeO-suc-AAPV-DOPE liposomes
`pre-
`pared at 1:3, 1:1, and 3:1 mol ratios were pretreated
`with or without elastase and incubated with HL60
`cells under low pH conditions to promote DODAP
`mediated binding to cells. Only DODAP/MeO-suc-
`AAPV-DOPE liposomes at a 1:1 mol ratio exhibited
`an elastase dependent increase in binding and lipid
`mixing with HL60 cells (Fig. 3), possibly as a result
`of increased positive charge after enzymatic cleavage.
`Apparently the amount of DODAP in 1:3 liposomes
`was insu⁄cient to mediate binding to cells, even at
`pH 5 after elastase treatment. By contrast, DODAP/
`MeO-suc-AAPV-DOPE (3:1 mol ratio) liposomes
`were able to bind to cells with or without elastase
`treatment, re£ecting the greater amount of DODAP
`in these liposomes. These liposomes were also able to
`lipid mix with cells even without elastase activation.
`The DODAP/MeO-suc-AAPV-DOPE 1:1 mol ratio
`liposomal formulation was chosen for all further
`studies in order to develop a delivery system that
`can be triggered by enzymatic cleavage.
`
`3.3. Elastase activated binding and lipid mixing of
`DODAP/MeO-suc-AAPV-DOPE liposomes with
`HL60 cells
`
`Since DODAP was included in liposomes with
`MeO-suc-AAPV-DOPE to enhance binding with
`cells under
`low pH conditions, we determined
`
`Fig. 4. pH dependence of DODAP/MeO-suc-AAPV-DOPE
`liposome binding/lipid mixing with HL60 cells. Fluorescent lipid
`probe labeled DODAP/MeO-suc-AAPV-DOPE liposomes were
`incubated with or without elastase (5 Wg elastase/100 nmol lip-
`id) for 2 h at 37‡C. 10 nmol of liposomes were mixed with
`1U106 HL60 cells in 200 Wl TES/NaCl/EDTA bu¡er. Samples
`were incubated for 30 min at 37‡C, at
`the given pH and
`washed. Binding (A) and lipid mixing (B) were determined by
`monitoring N-Rho-PE and N-NBD-PE £uorescence, respec-
`tively.
`
`whether the pH dependence of DODAP mediated
`binding is within physiological
`levels. DODAP/
`MeO-suc-AAPV-DOPE (1:1) liposomes were pre-
`treated with elastase and incubated with HL60 cells
`at di¡erent pH. Enhanced binding and lipid mixing
`of elastase pretreated liposomes with HL60 cells were
`observed when incubated at pH 4.6 or pH 5.1 (Fig.
`4). Incubation at pH 5.8^7.4 did not yield any sig-
`ni¢cant association of liposomes with cells. These
`results suggest that these liposomes are sensitive to
`elastase mediated activation of binding and lipid
`mixing when DODAP is maximally positively
`charged. The pH required to achieve this state is
`present under normal physiological conditions within
`the late endosome [30].
`To con¢rm that the enzymatic activity of elastase
`
`BBAMEM 77557 8-7-99 Cyaan Magenta Geel Zwart
`
`

`

`C.C. Pak et al. / Biochimica et Biophysica Acta 1419 (1999) 111^126
`
`119
`
`microscopy of liposomes with HL60 cells con¢rmed
`that elastase pretreatment was required for enhanced
`binding and lipid mixing. Bright £uorescent labeled
`cells indicate the N-Rho-PE £uorescent probe from
`the bound elastase activated liposomes had mixed
`into the cell plasma membrane (Fig. 6). In contrast,
`untreated liposomes displayed signi¢cantly less bind-
`ing and lipid mixing (Fig. 6). Quantitation of £uo-
`rescence images revealed nearly 12 times as much
`£uorescence/cell area in HL60 cells that had been
`incubated with DODAP/MeO-suc-AAPV-DOPE lip-
`osomes treated with elastase, as compared to those
`cells incubated with untreated liposomes, although
`the distribution of this enhanced delivery may not
`be uniform across all the cells. Almost no £uores-
`cence was associated with the cells at pH 7.4 (unpub-
`lished data).
`
`3.4. Aqueous contents delivery from
`DODAP/MeO-suc-AAPV-DOPE liposomes to
`HL60 cells
`
`To determine if the enhanced lipid mixing between
`elastase activated DODAP/MeO-suc-AAPV-DOPE
`liposomes and HL60 cells is truly indicative of fu-
`sion, it is necessary to monitor the delivery of an
`aqueous probe from the liposome to the cell cyto-
`plasm. Therefore DODAP/MeO-suc-AAPV-DOPE
`liposomes were loaded with tetramethyl rhodamine
`labeled 10 000 MW dextran (TMR-dextran), treated
`with or without elastase, and incubated with HL60
`cells under pH 5 conditions.
`Only DODAP/MeO-suc-AAPV-DOPE liposomes
`that had been pretreated with elastase were capable
`of fusing with HL60 cells, as demonstrated by TMR-
`dextran labeling of the cytoplasm of these cells (Fig.
`7). HL60 cells incubated with liposomes that had not
`been treated with elastase contained little or no cy-
`toplasmic £uorescent dextran,
`indicating elastase
`cleavage was required to trigger the fusion of DO-
`DAP/MeO-suc-AAPV-DOPE liposomes with HL60
`cells. TMR-dextran delivery to

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket